Studies on a new class of potential antiangiogenic agents: nucleoside antimetabolite drugs.
D000818:Animals; D001011:Aorta / Q000166:cytology* / Q000187:drug effects; D002417:Cattle; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003853:Deoxyribonucleosides / Q000494:pharmacology; D004727:Endothelium / Q000166:cytology / Q000187:drug effects; D005260:Female; D009389:Neovascularization, Pathologic / Q000187:drug effects*; D011247:Pregnancy; D011741:Pyrimidine Nucleosides / Q000494:pharmacology*; D012263:Ribonucleosides / Q000494:pharmacology
D003853:Deoxyribonucleosides; D011741:Pyrimidine Nucleosides; D012263:Ribonucleosides